AbbVie (ABBV) shares climbed to an all-time high Tuesday, clearing a buy point. But while the stock's action was bullish, a risk factor enters the picture with the company's earnings report just days away. The stock climbed more than 3% in above-average volume. It rose above an alternate entry at 261.63, which is also the previous high notched on July…
Botox Maker Tops Buy Point, But Here Comes The Earnings Report
Kaynak: Yahoo Finance
İlgili Haberler
Global
China threatens retaliation against U.S. humanoid robot ban, says it 'severely damages' relations
CNBC Finance · 4 saat önce
Global
The U.S. wants Asia to use its AI — but China dominates cheaper models
CNBC Finance · 8 saat önce
Global
Jim Cramer says this post-earnings sell-off is a golden buying opportunity
Yahoo Finance · 8 saat önce
Global
Here are the last times the Dow dropped by 1,000 points and what happened next
CNBC Finance · 9 saat önce
Global
Stocks making the biggest moves after hours: Microsoft, Meta, Starbucks, Carvana and more
CNBC Finance · 10 saat önce
Yorumlar (0)
Giriş yaparak yorum yazabilirsin.
İlk yorumu sen yaz.